CanSino Biologics Inc. (688185.SS)

CNY 63.42

(0.21%)

Total Assets Summary of CanSino Biologics Inc.

  • CanSino Biologics Inc.'s latest annual total assets in 2023 was 9.36 Billion CNY , down -18.3% from previous year.
  • CanSino Biologics Inc.'s latest quarterly total assets in 2024 Q3 was 7.98 Billion CNY , down -1.84% from previous quarter.
  • CanSino Biologics Inc. reported annual total assets of 11.46 Billion CNY in 2022, down -3.41% from previous year.
  • CanSino Biologics Inc. reported annual total assets of 11.87 Billion CNY in 2021, up 75.96% from previous year.
  • CanSino Biologics Inc. reported quarterly total assets of 7.98 Billion CNY for 2024 Q3, down -1.84% from previous quarter.
  • CanSino Biologics Inc. reported quarterly total assets of 8.56 Billion CNY for 2024 Q1, down -8.55% from previous quarter.

Annual Total Assets Chart of CanSino Biologics Inc. (2023 - 2016)

Historical Annual Total Assets of CanSino Biologics Inc. (2023 - 2016)

Year Total Assets Total Assets Growth
2023 9.36 Billion CNY -18.3%
2022 11.46 Billion CNY -3.41%
2021 11.87 Billion CNY 75.96%
2020 6.74 Billion CNY 278.15%
2019 1.78 Billion CNY 124.22%
2018 795.87 Million CNY -8.14%
2017 866.36 Million CNY 165.61%
2016 326.17 Million CNY 0.0%

Peer Total Assets Comparison of CanSino Biologics Inc.

Name Total Assets Total Assets Difference
Hubei Jumpcan Pharmaceutical Co., Ltd. 18.14 Billion CNY 48.359%
Yabao Pharmaceutical Group Co., Ltd 3.85 Billion CNY -143.137%
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited 78.58 Billion CNY 88.077%
Harbin Pharmaceutical Group Co., Ltd. 14.11 Billion CNY 33.606%
Tasly Pharmaceutical Group Co., Ltd 16.71 Billion CNY 43.943%
Zhejiang Medicine Co., Ltd. 12.77 Billion CNY 26.683%
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited 10.23 Billion CNY 8.411%
Lionco Pharmaceutical Group Co.,Ltd. 1.62 Billion CNY -476.747%
Humanwell Healthcare (Group) Co.,Ltd. 36.2 Billion CNY 74.12%
Ginwa Enterprise (Group) Inc. 2.1 Billion CNY -344.362%
Joincare Pharmaceutical Group Industry Co.,Ltd. 36.35 Billion CNY 74.23%
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. 2.17 Billion CNY -331.72%
China Animal Husbandry Industry Co., Ltd. 8.94 Billion CNY -4.731%
Jiangsu Jibeier Pharmaceutical Co., Ltd. 2.2 Billion CNY -324.028%
Zhejiang Huahai Pharmaceutical Co., Ltd. 18.59 Billion CNY 49.626%
Shanghai Haoyuan Chemexpress Co., Ltd. 4.19 Billion CNY -123.501%
Ningbo Menovo Pharmaceutical Co., Ltd. 4.42 Billion CNY -111.814%
Zhejiang Jiuzhou Pharmaceutical Co., Ltd 10.85 Billion CNY 13.66%
Chongqing Taiji Industry(Group) Co.,Ltd 14.41 Billion CNY 34.986%
HPGC Renmintongtai Pharmaceutical Corporation 7.42 Billion CNY -26.165%
Nanjing Well Pharmaceutical Group Co.,Ltd. 2.27 Billion CNY -311.146%
Tianjin Tianyao Pharmaceuticals Co., Ltd. 6.14 Billion CNY -52.538%
Henan Lingrui Pharmaceutical Co., Ltd. 4.77 Billion CNY -96.349%
Shenzhen Chipscreen Biosciences Co., Ltd. 3.2 Billion CNY -192.503%
Guizhou Yibai Pharmaceutical Co., Ltd. 4.78 Billion CNY -96.002%
Jiangsu Kanion Pharmaceutical Co.,Ltd. 7.11 Billion CNY -31.645%
Zhongzhu Healthcare Holding Co.,Ltd 3.01 Billion CNY -210.374%
Beijing Tongrentang Co., Ltd 30.08 Billion CNY 68.861%
KPC Pharmaceuticals, Inc. 9.59 Billion CNY 2.313%
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. 2.87 Billion CNY -225.708%
North China Pharmaceutical Company Ltd. 20.95 Billion CNY 55.291%
China Resources Double-Crane Pharmaceutical Co.,Ltd. 15.49 Billion CNY 39.537%
Tibet Weixinkang Medicine Co., Ltd. 1.77 Billion CNY -427.303%
China National Medicines Corporation Ltd. 32.45 Billion CNY 71.129%
Zhejiang Hisun Pharmaceutical Co., Ltd. 17.61 Billion CNY 46.804%
Heilongjiang ZBD Pharmaceutical Co., Ltd. 12.46 Billion CNY 24.838%
ChengDu ShengNuo Biotec Co.,Ltd. 1.31 Billion CNY -612.125%
Dali Pharmaceuticalco.,Ltd 473.83 Million CNY -1877.404%
Changchun BCHT Biotechnology Co. 5.04 Billion CNY -85.675%
Zhejiang Shengda Bio-Pharm Co., Ltd. 1.71 Billion CNY -445.003%
Shanghai Jiaoda Onlly Co.,Ltd 815.09 Million CNY -1049.511%
Jiang Zhong Pharmaceutical Co.,Ltd 6.12 Billion CNY -52.885%
Mayinglong Pharmaceutical Group Co., LTD. 4.82 Billion CNY -94.007%
Cisen Pharmaceutical Co., Ltd. 7.33 Billion CNY -27.689%
Hunan Warrant Pharmaceutical Co.,Ltd 2.17 Billion CNY -330.402%
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. 114.03 Billion CNY 91.783%
Jianmin Pharmaceutical Group Co.,Ltd. 4.16 Billion CNY -124.801%
Hunan Fangsheng Pharmaceutical Co., Ltd. 3.08 Billion CNY -204.111%
Guangxi Wuzhou Zhongheng Group Co.,Ltd 11.66 Billion CNY 19.684%
Guobang Pharma Ltd. 10.36 Billion CNY 9.574%
Shaanxi Kanghui Pharmaceutical Co., Ltd. 2.05 Billion CNY -356.67%
Kangmei Pharmaceutical Co., Ltd. 14.28 Billion CNY 34.388%
Shandong Buchang Pharmaceuticals Co., Ltd. 20.89 Billion CNY 55.153%
Zhejiang Starry Pharmaceutical Co.,Ltd. 5.51 Billion CNY -69.775%
Henan Taloph Pharmaceutical Stock Co.,Ltd 3.57 Billion CNY -161.951%
ZhuZhou QianJin Pharmaceutical Co.,Ltd 4.67 Billion CNY -100.339%
Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd 9.52 Billion CNY 1.624%
Beijing Sun-Novo Pharmaceutical Research Co., Ltd. 1.86 Billion CNY -402.926%
Shanghai Shyndec Pharmaceutical Co., Ltd. 19.35 Billion CNY 51.584%
Shanghai Yizhong Pharmaceutical Co., Ltd. 1.57 Billion CNY -495.516%
Tibet Rhodiola Pharmaceutical Holding Co. 4.58 Billion CNY -104.248%
Sichuan Huiyu Pharmaceutical Co., Ltd. 4.68 Billion CNY -99.964%
Zhejiang Cheng Yi Pharmaceutical Co., Ltd. 1.89 Billion CNY -395.022%
Jiangsu Lianhuan Pharmaceutical Co., Ltd. 2.85 Billion CNY -228.102%
Shandong Lukang Pharmaceutical Co.,Ltd. 8.8 Billion CNY -6.443%